Is Most-Watched Stock McKesson Corporation (MCK) Worth Betting on Now?

Despite recent underperformance with shares down 4.4% over the past month, McKesson (MCK) exhibits solid fundamental prospects, including projected double-digit year-over-year growth in current quarter EPS (+21.2%) and revenue (+10.8%), alongside beating Q4 consensus estimates for both. Although earnings estimates have seen minor negative revisions, MCK holds a Zacks Rank #3 (Hold) and an 'A' Zacks Value Style Score, suggesting it trades at a discount to peers and is anticipated to perform in line with the broader market in the near term.

Analysis

McKesson Corporation (MCK) presents a dichotomy between its recent market performance and its underlying fundamental strength. The stock has underperformed, returning -4.4% over the past month against a +1.3% gain for the S&P 500 composite. This contrasts sharply with robust growth projections, including an expected +21.2% year-over-year (YoY) increase in current quarter earnings and a +10.8% rise in revenue. For the full fiscal year, consensus estimates point to +12.5% EPS growth and +13.3% revenue growth. The company's last reported quarter further supports this, with revenue up +23.4% YoY, surpassing estimates by 1.82%. Despite these strong operational metrics and a history of beating EPS estimates in three of the last four quarters, sentiment appears tempered. Sell-side analyst estimates for the current quarter, current year, and next year have all seen minor negative revisions of approximately -0.4% over the last 30 days. This has contributed to a Zacks Rank #3 (Hold), suggesting the stock is expected to perform in line with the market. However, with a Zacks Value Style Score of 'A', the company is identified as trading at a discount relative to its peers, creating a conflicting but potentially interesting profile for investors.

Key Decisions for Investors

• Given the stock's recent -4.4% decline coupled with a top-tier 'A' value score and double-digit growth projections, value-oriented investors may consider the current price an attractive entry point.
• The Zacks Rank #3 (Hold) and minor negative earnings estimate revisions suggest a lack of immediate upward catalysts, warranting a patient approach as the stock is expected to perform in line with the broader market in the near term.
• Investors should monitor for any stabilization or positive turn in earnings estimate revisions, as this would be a key signal that analyst sentiment is catching up to the company's strong fundamental performance and could precede a price recovery.